Randomized controlled trials evaluating the impact of preoperative albumin supplementation on postoperative outcomes would be particularly valuable, as they could provide insight into whether correcting hypoalbuminemia can improve patient prognosis. The gene discussed is ALB; the disease is Hypoalbuminemia.